second Covid-19 vaccine produced by the Vector Institute by September-end, according to a report. "Our colleagues are focusing on one vaccine, the peptide vaccine, its clinical trials are now being completed.
30 September is the final date", Anna Popova, the head of the Rospotrebnadzor public health watchdog, said on Monday, according to RIA news agency.
Earlier, Deputy Prime Minister Tatyana Golikova said that clinical trials of Russia’s second coronavirus vaccine is set to be concluded in late September. "14 persons were vaccinated during the first phase, and 43 more during the second phase.
Forty-three more volunteers from the placebo control group received a placebo", a Russian official said, according to Sputnik News.If successful, the.